NCT01748500View on ClinicalTrials.gov

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Prostate Cancer
Interventions
DRUG

Pantoprazole

Trial Locations (1)

M5G2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01748500 - Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter